Last updated on December 2019

An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease


Brief description of study

This study will evaluate the long-term safety and tolerability of UTTR1147A in participants with moderate to severe ulcerative colitis (UC) or Crohn's disease (CD), enrolling up to 320 participants from the Phase Ib Study GA29469 and Phase II Study GA39925 (parent studies).

Clinical Study Identifier: NCT03650413

Find a site near you

Start Over

QWay Research

Hialeah, FL United States
  Connect »

University of Miami

Miami, FL United States
  Connect »

Chevy Chase Clinical Research

Chevy Chase, MD United States
  Connect »

Southtowns Gastroenterology, PLLC

Orchard Park, NY United States
  Connect »

Carolina Digestive Diseases

Greenville, NC United States
  Connect »

Gastro One

Germantown, TN United States
  Connect »

Baylor College of Medicine

Houston, TX United States
  Connect »

BI Research Center

Houston, TX United States
  Connect »

ETG Kielce

Kielce, Poland
  Connect »

Atlantic Health System

Morristown, NJ United States
  Connect »

Saint Martyr Elizabeth City Hospital

Sankt-peterburg, Russian Federation
  Connect »

Kuban State Medical University

Krasnodar, Russian Federation
  Connect »

Medical University Reaviz

Samara, Russian Federation
  Connect »

Kings College Hospital

London, United Kingdom
  Connect »

Royal Victoria Infirmary

Newcastle upon Tyne, United Kingdom
  Connect »

Klimed Marek Klimkiewicz

Piotrków Trybunalski, Poland
  Connect »

PlanetMed

Wroc?aw, Poland
  Connect »